"10.1371_journal.pone.0070867","plos one","2013-08-14T00:00:00Z","Elizabeth P Schlaudecker; Mark C Steinhoff; Saad B Omer; Monica M McNeal; Eliza Roy; Shams E Arifeen; Caitlin N Dodd; Rubhana Raqib; Robert F Breiman; K Zaman","Cincinnati Childrens Hospital and Medical Center, Division of Infectious Diseases, Global Health Center, Cincinnati, Ohio, United States of America; Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America; International Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh; United States Centers for Disease Control and Prevention, Nairobi, Kenya","Conceived and designed the experiments: MCS SBO ER SEA RR RFB KZ. Performed the experiments: EPS MMM KZ. Analyzed the data: EPS MCS MMM CND KZ. Contributed reagents/materials/analysis tools: MMM CND. Wrote the paper: EPS MCS SBO MMM ER SEA CND RR RFB KZ.","MCS reports receiving research support from Wyeth and Sanofi-Aventis for other studies and lecture fees from GlaxoSmithKline, Aventis Pasteur, and Sanofi-Aventis. This study was also partly funded by Aventis Pasteur. Fluarix is a GlaxoSmithKline product, but this product was purchased directly from the manufacturer with no funding support from GlaxoSmithKline. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","08","Elizabeth P Schlaudecker","EPS",10,TRUE,7,3,5,10,TRUE,TRUE,FALSE,0,NA,FALSE
